Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Volitionrx Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Volitionrx Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Forterre Gael | Chief Commercial Officer | 331,338 | Mar 19, 2026 | 7 |
| Rootsaert Rodney Gerard | Secretary | 273,993 | Mar 19, 2026 | 7 |
| Micallef Jacob Vincent | Chief Scientific Officer | 572,179 | Mar 19, 2026 | 4 |
| Plummer Nicholas | GC - Volition Diagnostics | 407,267 | Mar 19, 2026 | 7 |
| Reynolds Cameron John | President and CEO | 3,115,547 | Feb 27, 2026 | 4 |
| Innes Guy Archibald | Director | 1,252,967 | Feb 27, 2026 | 3 |
| Kway Jasmine | CEO - Singapore Volition | 418,614 | Feb 27, 2026 | 2 |
| Hughes Terig | Chief Financial Officer | 684,970 | Feb 27, 2026 | 2 |
| Nguyen Kim | Director | 305,816 | Feb 27, 2026 | 2 |
| Batchelor Ann-Louise | Group Chief Marketing Officer | 324,072 | Feb 27, 2026 | 3 |
| Rubin Ethel | Director | 252,948 | Feb 27, 2026 | 2 |
| Still Timothy I | Director | 1,625,458 | Jan 23, 2026 | 2 |
| Colman Alan | Director | 257,364 | Jan 23, 2026 | 1 |
| Barnes Phillip | Director | 67,368 | Jan 23, 2026 | 1 |
| Butera Salvatore Thomas | CEO - Volition Veterinary | 375,203 | Jan 23, 2026 | 3 |
| Henshall Mickie | Director | 44,206 | Jan 23, 2026 | 1 |
| Retter Andrew | Chief Medical Officer | 146,568 | Nov 4, 2025 | 1 |
| Gaetan Michel | Chief Operating Officer | 256,746 | Oct 7, 2025 | 1 |
| Futcher Edward | Director | 80,436 | Jan 26, 2024 | 0 |
| Faulkes Martin Charles | Executive Director | 1,740,207 | Jan 26, 2024 | 0 |
| Hever Investments Ltd | 10% Owner | 298,419Indirect | Jan 3, 2024 | 0 |
| Eight Corp Ltd | 10% Owner | 298,419Indirect | Jan 3, 2024 | 0 |
| Brudnick Richard | Director | 27,936 | Jan 13, 2023 | 0 |
| Terrell Jason Bradley MD | Chief Medical Officer | 2,326Indirect | Aug 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2022 (view filing) | Sep 19 | 1 day | Micallef Jacob VincentChief Scientific Officer | PPurchase | +13.0K | $1.70 | +$22.1K | +59.1%35.0K after | |
| Aug 30, 2022 (view filing) | Aug 30 | Same day | Reynolds Cameron JohnPresident and CEO | PPurchase | +3.50K | $1.61 | +$5.63K | +0.3%1.20M after | |
| Aug 30, 2022 (view filing) | Aug 26 | 4 days | Micallef Jacob VincentChief Scientific Officer | PPurchase | +29.0K | $1.74 | +$50.5K | +24.1%149.2K after | |
| Aug 24, 2022 (view filing) | Aug 23 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $1.60 | +$8.00K | +3.1%165.0K after | From original |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $1.64 | +$8.20K | +3.2%160.0K after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Innes Guy ArchibaldDirector | PPurchase | +12.5K | $2.00 | +$25.0K | +0.8%1.56M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Innes Guy ArchibaldDirector | PPurchase | +300.0K | $2.00 | +$600.0K | New position75.0K after | 4 lots |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $2.05 | +$20.5K | +6.9%155.0K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Terrell Jason Bradley MDChief Medical Officer | SSale | −14.9K | $2.47 | −$36.9K | −54.9%12.3K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +10.0K | $2.37 | +$23.7K | +0.7%1.55M after | |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Terrell Jason Bradley MDChief Medical Officer | SSale | −10.0K | $2.75 | −$27.5K | −26.8%27.2K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Butera Salvatore ThomasCEO-Volition Veterinary | PPurchase | +10.0K | $4.02 | +$40.2K | New position10.0K after |